Spatial biology tools useful for disease monitoring
AssigneeSingular Genomics Systems, Inc.
InventorsEli N. GLEZER, Michael LAWSON, Kenneth Howard GOUIN, III
Life of this patent
Estimating the term…
Abstract
Disclosed herein, inter alia, are oligonucleotide probes, methods, and kits useful for amplifying and detecting target nucleic acids in situ.
Claims20
A probe panel comprising a plurality of oligonucleotide probes, wherein each oligonucleotide probe comprises:
- a first hybridization sequence designed to specifically bind to a first target sequence of an RNA molecule and a second hybridization sequence designed to specifically bind to a second target sequence of the RNA molecule,
- wherein the probe panel is configured to detect at least 25 RNA molecules associated with inflammatory bowel disease (IBD).
A method for detecting a nucleic acid molecule in a tissue, said method comprising:
- immobilizing a tissue to a solid support, wherein the tissue comprises a nucleic acid molecule and is selected from colon tissue, rectal tissue, ileal tissue, small intestine tissue, gastric tissue, esophageal tissue, perianal tissue, fibrotic tissue, and granulomatous tissue;
- contacting the tissue with an oligonucleotide probe, wherein said oligonucleotide probe comprises a first hybridization sequence and a second hybridization sequence;
- hybridizing the first hybridization sequence to the nucleic acid molecule and hybridizing the second hybridization sequence to the nucleic acid molecule;
- ligating the first hybridization sequence to the second hybridization sequence to form a circular polynucleotide;
- amplifying the circular polynucleotide to form an amplification product;
- and
- sequencing a sequence of the amplification product.
A method of detecting nucleic acid molecules in a tissue sample from a patient having or suspected of having inflammatory bowel disease (IBD), the method comprising:
- i) contacting the tissue sample with a first polynucleotide probe and binding said first polynucleotide probe to a first nucleic acid molecule, and contacting the sample with a second polynucleotide probe and binding said second polynucleotide probe to a second nucleic acid molecule, wherein said first polynucleotide probe comprises a first oligonucleotide binding sequence and a first sequence, and wherein said second polynucleotide probe comprises a second oligonucleotide binding sequence and a second sequence;
- ii) amplifying the first and second polynucleotide probes to generate amplification products;
- iii) hybridizing a first oligonucleotide to the first hybridization sequence and detecting a series of fluorescent signals associated with the first sequence to determine the first nucleic acid molecule and a location of the first nucleic acid molecule, followed by hybridizing a second oligonucleotide to the second oligonucleotide binding sequence, and detecting a series of fluorescent signals associated with the second sequence to determine the second nucleic acid molecule and a location of the second nucleic acid molecule, wherein the first oligonucleotide and the second oligonucleotide comprise different sequences;
- and
- iv) generating an image of the tissue sample comprising indicia data corresponding to the locations of the first and second nucleic acid molecules.
A solid support comprising a plurality of discrete tissue samples obtained from a patient having or suspected of having inflammatory bowel disease (IBD),
- wherein each tissue sample is selected from colon tissue, rectal tissue, ileal tissue, small intestine tissue, gastric tissue, esophageal tissue, perianal tissue, fibrotic tissue, or granulomatous tissue;
- wherein each tissue sample comprises:
- (i) an RNA molecule hybridized to an oligonucleotide probe, the RNA molecule comprising a sequence of an IBD-associated gene;
- and (ii) a protein bound to a specific binding reagent, the protein being an IBD-associated protein.
Dependencies are inferred from the claim text.